NCT03336541View on ClinicalTrials.gov

Low-dose Ketamine and Postpartum Depression in Parturients With Prenatal Depression

PHASE4CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

November 23, 2017

Primary Completion Date

May 14, 2018

Study Completion Date

June 25, 2018

Conditions
Perinatal DepressionKetamineCesarean DeliveryPostpartum Depression
Interventions
DRUG

Ketamine

Ketamine (0.5 mg/kg in 100 ml normal saline) will be administered by intravenous infusion in 40 minutes after childbirth during cesarean delivery.

DRUG

Placebo

Placebo (100 ml normal saline) will be administered by intravenous infusion in 40 minutes after childbirth during cesarean delivery.

Trial Locations (1)

100034

Department of Anesthesiology and Critical Care Medicine, Peking University First Hospital, Beijing

All Listed Sponsors
lead

Peking University First Hospital

OTHER

NCT03336541 - Low-dose Ketamine and Postpartum Depression in Parturients With Prenatal Depression | Biotech Hunter | Biotech Hunter